Back to News
Market Impact: 0.3
Quest Diagnostics: 3 Key Takeaways for Long-Term Investors
Source: fool.com
Healthcare & BiotechCorporate Guidance & OutlookCompany Fundamentals
Quest Diagnostics expects consumer health revenue to grow more than 30% in 2026. Organic requisition volume increased 14.4% in the third quarter of 2026, supporting the positive growth outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
DGX0.60
More News
- What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
- AI debt and French bonds face a stress test — why it may not be over
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
- Why is SK Hynix stock sliding today?
- Apple’s iPhone Duo Hits Stores in Face of Short Supply and High Demand
- OpenAI nears up to $30 billion funding round at $1.25 trillion valuation led by UAE investors